BACKGROUND. Exogenous pulmonary surfactants are administered into the trachea either to prevent respiratory distress syndrome in premature infants or to treat it. In a randomized, multicenter trial, we compared the results of surfactant therapy initiated as prophylaxis with the results of rescue therapy with surfactant. METHODS. Before birth, 479 infants with an estimated gestational age of less than 30 weeks were randomly assigned to receive surfactant as prophylaxis (n = 235) or rescue therapy (n = 244). The infants in the prophylaxis group received a 90-mg intratracheal dose of an exogenous calf-lung surfactant extract at the time of delivery, whereas the infants in the rescue-therapy group received 90 mg of the surfactant several hours after delivery if the fractional inspiratory oxygen concentration was at least 0.40 or if the mean airway pressure was at least 0.686 kPa (7 cm of water), or both. Infants in both groups received additional doses of surfactant at intervals of 12 to 24 hours if these criteria were met. RESULTS. The proportion of infants surviving until discharge to their homes was significantly higher in the prophylaxis group than in the rescue-therapy group (88 vs. 80 percent, P = 0.028). This difference was due primarily to the longer survival of very premature infants (less than or equal to 26 weeks' gestation) in the prophylaxis group than in the rescue-therapy group (75 vs. 54 percent, P = 0.006). According to proportional-hazards regression analysis, the distribution of survival times was better for all infants in the prophylaxis group (P = 0.007) and for the subgroup of infants in the prophylaxis group who were delivered at 26 weeks' gestation or earlier (P = 0.0048). Infants in the prophylaxis group who were delivered at 26 weeks' gestation or earlier had a lower incidence of pneumothorax than similar infants in the rescue-therapy group (7 vs. 18 percent, P = 0.03). CONCLUSIONS. We found a significant advantage to the administration of the initial dose of surfactant as prophylaxis rather than as rescue therapy in very premature infants.
Source Information
Department of Pediatrics (Neonatology), University of Rochester School of Medicine, NY 14642.
This article has been cited by other articles:
Engle, W. A., and the Committee on Fetus and Newborn,
(2008). Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate. Pediatrics
121: 419-432
[Abstract][Full Text]
Ghodrat, M.
(2006). Lung surfactants.. Am J Health Syst Pharm
63: 1504-1521
[Abstract][Full Text]
Shashikant, B. N., Miller, T. L., Welch, R. W., Pilon, A. L., Shaffer, T. H., Wolfson, M. R.
(2005). Dose response to rhCC10-augmented surfactant therapy in a lamb model of infant respiratory distress syndrome: physiological, inflammatory, and kinetic profiles. J. Appl. Physiol.
99: 2204-2211
[Abstract][Full Text]
Agrons, G. A., Courtney, S. E., Stocker, J. T., Markowitz, R. I.
(2005). From the Archives of the AFIP: Lung Disease in Premature Neonates: Radiologic-Pathologic Correlation. RadioGraphics
25: 1047-1073
[Abstract][Full Text]
Anderson, J. C., Molthen, R. C., Dawson, C. A., Haworth, S. T., Bull, J. L., Glucksberg, M. R., Grotberg, J. B.
(2004). Effect of ventilation rate on instilled surfactant distribution in the pulmonary airways of rats. J. Appl. Physiol.
97: 45-56
[Abstract][Full Text]
Reiter, P. D, Sims, C., Harmes, L., Paisley, J., Rosenberg, A. A, Valuck, R. J
(2003). Calfactant Sterility in Multiple Doses from Single-Use Vials. The Annals of Pharmacotherapy
37: 1219-1223
[Abstract][Full Text]
Burch, K., Rhine, W., Baker, R., Litman, F., Kaempf, J. W., Schwarz, E., Sun, S., Payne, N. R., Sharek, P. J.
(2003). Implementing Potentially Better Practices to Reduce Lung Injury in Neonates. Pediatrics
111: e432-436
[Abstract][Full Text]
D'Angio, C. T., Sinkin, R. A., Stevens, T. P., Landfish, N. K., Merzbach, J. L., Ryan, R. M., Phelps, D. L., Palumbo, D. R., Myers, G. J.
(2002). Longitudinal, 15-Year Follow-up of Children Born at Less Than 29 Weeks' Gestation After Introduction of Surfactant Therapy Into a Region: Neurologic, Cognitive, and Educational Outcomes. Pediatrics
110: 1094-1102
[Abstract][Full Text]
Cassidy, K. J., Bull, J. L., Glucksberg, M. R., Dawson, C. A., Haworth, S. T., Hirschl, R., Gavriely, N., Grotberg, J. B.
(2001). A rat lung model of instilled liquid transport in the pulmonary airways. J. Appl. Physiol.
90: 1955-1967
[Abstract][Full Text]
Osborn, D. A., Jeffery, H. E., Bredemeyer, S. L., Polverino, J. M., Reid, S.
(2000). Targeted Early Rescue Surfactant in Ventilated Preterm Infants Using the Click Test. Pediatrics
106: 30e-30
[Abstract][Full Text]
Kattwinkel, J., Bloom, B. T., Delmore, P., Glick, C., Brown, D., Lopez, S., Willett, L., Egan, E. A., Conaway, M., Patrie, J.
(2000). High-Versus Low-Threshold Surfactant Retreatment For Neonatal Respiratory Distress Syndrome. Pediatrics
106: 282-288
[Abstract][Full Text]
Committee on Fetus and Newborn,
(1999). Surfactant Replacement Therapy for Respiratory Distress Syndrome. Pediatrics
103: 684-685
[Abstract][Full Text]
Verder, H., Albertsen, P., Ebbesen, F., Greisen, G., Robertson, B., Bertelsen, A., Agertoft, L., Djernes, B., Nathan, E., Reinholdt, J.
(1999). Nasal Continuous Positive Airway Pressure and Early Surfactant Therapy for Respiratory Distress Syndrome in Newborns of Less Than 30 Weeks' Gestation. Pediatrics
103: 24e-24
[Abstract][Full Text]
Gortner, L., Wauer, R. R., Hammer, H., Stock, G.-J., Heitmann, F., Reiter, H. L., Kühl, P. G., Möller, J. C., Friedrich, H.-J., Reiss, I., Hentschel, R., Jorch, G., Hieronimi, G., Kuhls, E.
(1998). Early Versus Late Surfactant Treatment in Preterm Infants of 27 to 32 Weeks' Gestational Age: A Multicenter Controlled Clinical Trial. Pediatrics
102: 1153-1160
[Abstract][Full Text]
Halpern, D., Jensen, O. E., Grotberg, J. B.
(1998). A theoretical study of surfactant and liquid delivery into the lung. J. Appl. Physiol.
85: 333-352
[Abstract][Full Text]
Kendig, J. W., Ryan, R. M., Sinkin, R. A., Maniscalco, W. M., Notter, R. H., Guillet, R., Cox, C., Dweck, H. S., Horgan, M. J., Reubens, L. J., Risemberg, H., Phelps, D. L.
(1998). Comparison of Two Strategies for Surfactant Prophylaxis in Very Premature Infants: A Multicenter Randomized Trial. Pediatrics
101: 1006-1012
[Abstract][Full Text]
Sinkin, R. A., Kramer, B. M., Merzbach, J. L., Myers, G. J., Brooks, J. G., Palumbo, D. R., Cox, C., Kendig, J. W., Mercier, C. E., Phelps, D. L.
(1998). School-age Follow-up of Prophylactic Versus Rescue Surfactant Trial: Pulmonary, Neurodevelopmental, and Educational Outcomes. Pediatrics
101
: e11-e11
[Abstract][Full Text]
Manuel, S. M., Guo, Y., Matalon, S.
(1997). Exosurf enhances adenovirus-mediated gene transfer to alveolar type II cells. Am. J. Physiol. Lung Cell. Mol. Physiol.
273: L741-L748
[Abstract][Full Text]
Bloom, B. T., Kattwinkel, J., Hall, R. T., Delmore, P. M., Egan, E. A., Trout, J. R., Malloy, M. H., Brown, D. R., Holzman, I. R., Coghill, C. H., Carlo, W. A., Pramanik, A. K., McCaffree, M. A., Toubas, P. L., Laudert, S., Gratny, L. L., Weatherstone, K. B., Seguin, J. H., Willett, L. D., Gutcher, G. R., Mueller, D. H., Topper, William. H
(1997). Comparison of Infasurf (Calf Lung Surfactant Extract) to Survanta (Beractant) in the Treatment and Prevention of Respiratory Distress Syndrome. Pediatrics
100: 31-38
[Abstract][Full Text]
Hudak, M. L., Martin, D. J., Egan, E. A., Matteson, E. J., Cummings, J., Jung, A. L., Kimberlin, L. V., Auten, R. L., Rosenberg, A. A., Asselin, J. M., Belcastro, M. R., Donohue, P. K., Hamm Jr, C. R., Jansen, R. D., Brody, A. S., Riddlesberger, M. M., Montgomery, P.
(1997). A Multicenter Randomized Masked Comparison Trial of Synthetic Surfactant Versus Calf Lung Surfactant Extract in the Prevention of Neonatal Respiratory Distress Syndrome. Pediatrics
100: 39-50
[Abstract][Full Text]
Egberts, J., Brand, R., Walti, H., Bevilacqua, G., MD, G. B., Gardini, F.
(1997). Mortality, Severe Respiratory Distress Syndrome, and Chronic Lung Disease of the Newborn Are Reduced More After Prophylactic Than After Therapeutic Administration of the Surfactant Curosurf. Pediatrics
100: e4-e4
[Abstract][Full Text]
Morley, C J
(1997). Systematic review of prophylactic vs rescue surfactant. Arch. Dis. Child. Fetal Neonatal Ed.
77: 70F-74
[Full Text]
Leach, C. L., Greenspan, J. S., Rubenstein, S. D., Shaffer, T. H., Wolfson, M. R., Jackson, J. C., DeLemos, R., Fuhrman, B. P., The LiquiVent Study Group,
(1996). Partial Liquid Ventilation with Perflubron in Premature Infants with Severe Respiratory Distress Syndrome. NEJM
335: 761-767
[Abstract][Full Text]
Verder, H., Robertson, B., Greisen, G., Ebbesen, F., Albertsen, P., Lundstrom, K., Jacobsen, T., The Danish-Swedish Multicenter Study Group,
(1994). Surfactant Therapy and Nasal Continuous Positive Airway Pressure for Newborns with Respiratory Distress Syndrome. NEJM
331: 1051-1055
[Abstract][Full Text]
Allen, M. C., Donohue, P. K., Dusman, A. E.
(1993). The Limit of Viability -- Neonatal Outcome of Infants Born at 22 to 25 Weeks' Gestation. NEJM
329: 1597-1601
[Abstract][Full Text]
Jobe, A. H.
(1993). Pulmonary Surfactant Therapy. NEJM
328: 861-868
[Full Text]
(1991). PROPHYLACTIC SURFACTANT IS SUPERIOR TO RESCUE THERAPY IN PREMATURE INFANTS. JWatch General
1991: 2-2
[Full Text]
